Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypofractionated Radiation Therapy (1 Week) Compared With Standard Treatment (3.1 Weeks), Evaluation of Local Control of Breast Cancer Treated With Conservative Surgery.

NCT05318274 is registered in ClinicalTrials.gov with Coordinación de Investigación en Salud, Mexico as lead sponsor.

NCT NCT05318274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05318274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypofractionated Radiation Therapy (1 Week) Compared With Standard Treatment (3.1 Weeks), Evaluation of Local Control of Breast Cancer Treated With Conservative Surgery.
Lead sponsor
Coordinación de Investigación en Salud, Mexico
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 26, 2021
Completion date
December 30, 2026
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ductal breast carcinoma in situ, early-stage breast cancer, invasive breast cancer, stage 0 breast cancer, stage i breast cancer, stage ia breast cancer, stage ib breast cancer